Back

Blood pressure lowering to reduce CV disease. An IPD analysis of 344,000 people.

30 August 2021 (09:42 - 09:54)
Organised by:
Congress Presentation Part of: The Lancet – Focus on Hypertension 2021 Other ESC Premium Access ESC Congress 2021 - The Digital Experience

About the speaker

Photo
Professor Kazem Rahimi

University of Oxford, Oxford (United Kingdom of Great Britain & Northern Ireland)

3 More presentations in this session

Presentation thumbnail
Worldwide prevalence trends in hypertension.
Doctor B. Zhou (London, GB)
Slides Video
Presentation thumbnail
RADIANCE HTN TRIO (ultrasound denervation RCT).
Professor M. Azizi (Paris, FR)
Slides Video
Presentation thumbnail
The Lancet – Focus on Hypertension 2021 discussion.

Access the full session

Session thumbnail
The Lancet – Focus on Hypertension 2021
Video

The Event

Event poster

ESC Congress 2021 - The Digital Experience

30 August 2021 09:42 CET
You may be interested in
thumbnail
Congress Presentation
Effects of blood pressure lowering according to baseline cardiovascular disease: systematic review and meta-analysis of randomized trials
27 August 2023
thumbnail
Congress Presentation
Design of a multicenter, open-label, randomized controlled trial: effects of intensive systolic blood pressure lowering treatment in reducing risk of vascular events (ESPRIT)
2 September 2019
thumbnail
Congress Presentation
Effect of blood pressure reduction on cardiovascular outcomes in patients with different baseline cardiovascular risk: systematic review and meta-analysis of randomized trials
28 August 2022
thumbnail
Congress Presentation
Why do we hesitate to intensify?
24 April 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources